Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Dormitol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1DECHRA REGULATORY BV

    02 2FRESENIUS KABI CANADA LTD

    03 1HIKMA CANADA LIMITED

    04 4NEURAXPHARM PHARMACEUTICALS, S.L.

    05 4PFIZER CANADA ULC

    06 2SANDOZ CANADA INCORPORATED

    07 1STERINOVA INC.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    DECHRA REGULATORY BV

    Denmark
    BPI Europe
    Not Confirmed
    arrow

    DECHRA REGULATORY BV

    Denmark
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : DORMAZOLAM

    Dosage Form : SOLUTION

    Dosage Strength : 5MG/ML

    Packaging :

    Approval Date :

    Application Number : 2517582

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    FRESENIUS KABI CANADA LTD

    Austria
    BPI Europe
    Not Confirmed
    arrow

    FRESENIUS KABI CANADA LTD

    Austria
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Austria
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : MIDAZOLAM INJECTION, USP

    Dosage Form : SOLUTION

    Dosage Strength : 1MG/ML

    Packaging : 2/5/10ML

    Approval Date :

    Application Number : 2242904

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    FRESENIUS KABI CANADA LTD

    Austria
    BPI Europe
    Not Confirmed
    arrow

    FRESENIUS KABI CANADA LTD

    Austria
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Austria
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : MIDAZOLAM INJECTION, USP

    Dosage Form : SOLUTION

    Dosage Strength : 5MG/ML

    Packaging : 1/2/10ML

    Approval Date :

    Application Number : 2242905

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    HIKMA CANADA LIMITED

    United Kingdom
    BPI Europe
    Not Confirmed
    arrow

    HIKMA CANADA LIMITED

    United Kingdom
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : MIDAZOLAM INJECTION USP

    Dosage Form : SOLUTION

    Dosage Strength : 1MG/ML

    Packaging :

    Approval Date :

    Application Number : 2553104

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    BPI Europe
    Not Confirmed
    arrow

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)

    Brand Name : BUCCOLAM

    Dosage Form : SOLUTION

    Dosage Strength : 2.5MG/0.5ML

    Packaging :

    Approval Date :

    Application Number : 2559579

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    BPI Europe
    Not Confirmed
    arrow

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)

    Brand Name : BUCCOLAM

    Dosage Form : SOLUTION

    Dosage Strength : 5MG/1ML

    Packaging :

    Approval Date :

    Application Number : 2559587

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    BPI Europe
    Not Confirmed
    arrow

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)

    Brand Name : BUCCOLAM

    Dosage Form : SOLUTION

    Dosage Strength : 7.5MG/1.5ML

    Packaging :

    Approval Date :

    Application Number : 2559595

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    BPI Europe
    Not Confirmed
    arrow

    NEURAXPHARM PHARMACEUTICALS, S.L.

    Spain
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)

    Brand Name : BUCCOLAM

    Dosage Form : SOLUTION

    Dosage Strength : 10MG/2ML

    Packaging :

    Approval Date :

    Application Number : 2559609

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    PFIZER CANADA ULC

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : MIDAZOLAM INJECTION USP

    Dosage Form : SOLUTION

    Dosage Strength : 1MG/ML

    Packaging : 2ML/5ML

    Approval Date :

    Application Number : 2382342

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    PFIZER CANADA ULC

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    MIDAZOLAM

    Brand Name : MIDAZOLAM INJECTION USP

    Dosage Form : SOLUTION

    Dosage Strength : 5MG/ML

    Packaging : 1/2ML

    Approval Date :

    Application Number : 2382350

    Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.